SCHEMBL4201146

SCHEMBL4201146

COc1cc(C(N)=O)ccc1OCCC1CCCN1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.54
CHRNB4 P30926 3/20 0.50
CHRNA3 P32297 3/20 0.50
CHEK2 O96017 1/20 0.50
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PRSS1 P07477 4/20 0.45
CHEK1 O14757 1/20 0.44
SSTR2 P30874 1/20 0.43
PDE4A P27815 2/20 0.43
PDE4B Q07343 2/20 0.43
PDE4C Q08493 2/20 0.43
PDE4D Q08499 2/20 0.43
KDM4E B2RXH2 1/20 0.42
PRKAB2 O43741 1/20 0.42
PRKAG1 P54619 1/20 0.42
PRKAA2 P54646 1/20 0.42
PRKAA1 Q13131 1/20 0.42
PRKAG3 Q9UGI9 1/20 0.42
PRKAG2 Q9UGJ0 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4263220 0.97 CHEK2 (0.54) MAPK1CHRNB4CHRNA3CHEK2HPGD
SCHEMBL5240271 0.85 CHEK2 (0.51) CHRNB4CHRNA3CHEK2HPGDSSTR2
SCHEMBL2172629 0.82 CHRNB4 (0.51) MAPK1CHRNB4CHRNA3HPGDCHEK1
SCHEMBL4264616 0.81 MAPK1 (0.56) MAPK1CHEK2HPGDHSD17B10PRSS1
SCHEMBL11456174 0.80 CHRNB4 (0.74) CHRNB4CHRNA3CHEK1
SCHEMBL2330776 0.80 CHRNB4 (0.50) CHRNB4CHRNA3HPGDCHEK1SSTR2
SCHEMBL7006966 0.80 CHRNB4 (0.55) MAPK1CHRNB4CHRNA3CHEK1SSTR2
SCHEMBL11457361 0.79 CHRNB4 (0.54) CHRNB4CHRNA3CHEK2CHEK1
SCHEMBL6073293 0.79 ROCK2 (0.55) MAPK1CHEK2HPGDPRSS1
SCHEMBL2332409 0.79 FDPS (0.60) CHRNB4CHRNA3HPGDCHEK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029609-A2 NOVEL MCH RECEPTOR ANTAGONISTS Eli Lilly & Company (US) 2009-03-04 EP disclosed
EP-1987042-A2 NOVEL AMINO ALCOHOL-SUBSTITUTED ARYLTHIENOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS sanofi-aventis (FR) 2008-11-05 EP disclosed
WO-2007146758-A2 NOVEL MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2007-12-21 WO disclosed
EP-1828207-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2007-09-05 EP disclosed
WO-2007093365-A2 NOVEL AMINO ALCOHOL-SUBSTITUTED ARYLTHIENOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS SANOFI-AVENTIS (DE) 2007-08-23 WO disclosed
WO-2006066174-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2006-06-22 WO disclosed
EP-1436267-A1 LACTAM DERIVATIVES AS ANTAGONISTS FOR HUMAN 11CBY RECEPTORS SMITHKLINE BEECHAM PLC (GB) 2004-07-14 EP disclosed
EP-1305304-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE AS ANTAGONISTS OF A HUMAN 11CBY RECEPTOR SMITHKLINE BEECHAM PLC (GB) 2003-05-02 EP disclosed
WO-2003033480-A1 LACTAM DERIVATIVES AS ANTAGONISTS FOR HUMAN 11CBY RECEPTORS SMITHKLINE BEECHAM PLC (GB) 2003-04-24 WO disclosed
WO-2002010146-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE AS ANTAGONISTS OF A HUMAN 11CBY RECEPTOR SMITHKLINE BEECHAM P.L.C. (GB) 2002-02-07 WO disclosed